Neuraxis revenue was $2.69M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $761.2k, up 14.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NRXS annual revenue was $2.7M, with 9.2% growth year-over-year.
NRXS past revenue growth
How has NRXS's revenue growth performed historically?
Neuraxis (NYSEMKT: NRXS) reported Q4 2024 revenue of $761.17 thousand up 43.22% year over year. In the same quarter last year, Neuraxis's revenue was $531.46 thousand.
What was Neuraxis's revenue in 2024?
Neuraxis's annual revenue for the twelve months ending Dec 31, 2024 was $2.69 million, a 9.18% increase year over year.
How much does Neuraxis make in a day?
Based on Neuraxis annual revenue for the past four years, NRXS makes an average of $7,227.39 per day.
What was Neuraxis's annual revenue growth in the past year?
As of Q2 2025, Neuraxis's revenue has grown 9.18% year over year. This is 488.51 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Neuraxis's revenue in the past year totaled $2.69 million.
How much does Neuraxis make in a year?
Neuraxis's revenue by year for the past four years is:
Neuraxis's revenue for the twelve months ending Dec 31, 2024 was $2.69 million, a 9.18% increase year over year.
Neuraxis's annual revenue for Dec 31, 2023 was $2.46 million, a 8.37% decrease from 2022.
Neuraxis's annual revenue for 2022 was $2.68 million, a 1.34% decrease from 2021.
Neuraxis's annual revenue for 2021 was $2.72 million, a 24.82% increase from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.